Bacteriophages, or simply phages, are viruses that specifically target and infect bacteria. These microscopic entities play a crucial role in the regulation of bacterial populations in various environments, contributing to the balance of microbial ecosystems. Bacteriophages are incredibly diverse, displaying a wide range of shapes and genetic compositions. They have a unique life cycle that involves attaching to a bacterial host, injecting their genetic material, and subsequently replicating within the host cell, leading to its destruction. Beyond their ecological role, bacteriophages have gained attention as potential therapeutic agents against bacterial infections. Phage therapy involves using specific bacteriophages to target and kill pathogenic bacteria. This approach holds promise as an alternative or complement to traditional antibiotics, especially in the face of rising antibiotic resistance. Research in phage therapy explores the identification and isolation of potent phages, understanding their interactions with bacterial hosts, and optimizing delivery methods for effective treatment.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain